Chronic Kidney Failure: Clinical Trials

3 trials for Chronic Kidney Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Terminated 3

Follow Chronic Kidney Failure: new trials by email Literature Review of Chronic Kidney Failure trials Research Report on Chronic Kidney Failure

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate
Magnesium iron hydroxycarbonate, Lanthanum carbonate, Placebo - Chronic Kidney Failure
Phase 3TerminatedIneos Healthcare Limited6572009-07-012010-10-19
Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride
Fermagate, Sevelamer hydrochloride - Chronic Kidney Failure
Phase 3TerminatedIneos Healthcare Limited10002009-07-012010-10-19
Evaluation of a Third and Fourth Dose of StaphVAX® in Adults With End-Stage Renal Disease
Staph aureus types 5 and 8 conjugate vaccine, placebo - Staphylococcal Infections, Chronic Kidney Failure
Phase 3TerminatedNabi Biopharmaceuticals992005-08-012008-01-04

Narrower conditions

Kidney Failure, Chronic (3)  ·  Hyperphosphatemia (2)  ·  Staphylococcal Infections (1)

Broader conditions

Chronic Disease (3)  ·  Disease Attributes (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Kidney Diseases (3)  ·  Male Urogenital Diseases (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Renal Insufficiency (3)  ·  Renal Insufficiency, Chronic (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Phosphorus Metabolism Disorders (2)

Interventions

iron-magnesium hydroxycarbonate (2)  ·  Sevelamer (1)  ·  StaphVax (1)  ·  lanthanum carbonate (1)

Sponsors

Ineos Healthcare Limited (2)  ·  Nabi Biopharmaceuticals (1)

Countries

United States (3)  ·  Brazil (2)  ·  South Africa (2)  ·  Australia (1)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Czechia (1)  ·  Estonia (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Israel (1)  ·  Italy (1)  ·  Lithuania (1)

Top investigators

Matt Hohenboken, MD, PhD (1)

NIH funding

2008 (2)